Schedule 13D ownership disclosure
PROTEOSTASIS THERAPEUTICS, INC.
Security class unavailable · CUSIP: 74373B109
Event date: 2016-02-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000690
- Form type
- SC 13D
- Filer
- New Enterprise Associates 12, Limited Partnership
- CIK
- CIK 1383391
- Filed
- Feb 26, 2016
- Reporting period
- Feb 17, 2016
- Description
- Schedule 13D beneficial ownership